CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

NCT04050280 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia, Adult
Acute Myeloid Leukemia Recurrent
Acute Myeloid Leukemia, Relapsed, Adult

Interventions

DRUG: Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO)

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]